Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease

被引:8
|
作者
van Son, Koen C. [1 ,2 ]
Verschuren, Lars [3 ]
Hanemaaijer, Roeland [3 ]
Reeves, Helen [4 ]
Takkenberg, R. Bart [5 ]
Drenth, Joost P. H. [2 ]
Tushuizen, Maarten E. [6 ]
Holleboom, Adriaan G. [1 ]
机构
[1] Univ Amsterdam, Med Ctr, Dept Vasc & Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 GA Nijmegen, Netherlands
[3] Netherlands Org Appl Sci Res, Dept Metab Hlth Res, NL-2333 BE Leiden, Netherlands
[4] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne NE2 4HH, England
[5] Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[6] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 ZA Leiden, Netherlands
关键词
non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; hepatocellular carcinoma; hepatocarcinogenesis; non-parenchymal cells; hepatic stellate cells; macrophages; liver sinusoidal endothelial cells; immune surveillance; HEPATIC STELLATE CELLS; INSULIN-RESISTANCE; KUPFFER CELLS; T-CELLS; MOLECULAR-MECHANISMS; ACTIVATED MONOCYTES; PERITUMORAL STROMA; FIBROSIS STAGE; DNA-DAMAGE; DUAL ROLE;
D O I
10.3390/cancers15041308
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary The incidence of hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) has increased in recent years. Compared to HCC caused by other chronic liver diseases, NAFLD-related HCC is often detected later, because it more commonly arises before cirrhosis has occurred. Because of this late diagnosis, NAFLD-related HCC is often more advanced at time of diagnosis, resulting in fewer curative treatment options. Most research in the pathogenesis of HCC has focused on the disease processes in hepatocytes, the most abundant type of liver cells. However, other cell types, such as cells of the immune system and cells that regulate connective tissue formation, also play an important role in the development of NAFLD-related HCC, both by contributing to the development of HCC itself and by interfering with the immune system's ability to attack cancer cells. In this paper, we review the role of different cell types in the development of NAFLD-related HCC. Hepatocellular carcinoma (HCC) in the setting of non-alcoholic fatty liver disease (NAFLD)-related cirrhosis and even in the pre-cirrhotic state is increasing in incidence. NAFLD-related HCC has a poor clinical outcome as it is often advanced at diagnosis due to late diagnosis and systemic treatment response is poor due to reduced immune surveillance. Much of the focus of molecular research has been on the pathological changes in hepatocytes; however, immune cells, hepatic stellate cells, liver sinusoidal endothelial cells and the extracellular matrix may play important roles in the pathogenesis of NAFLD-related HCC as well. Here, we review the role of non-parenchymal cells in the liver in the pathogenesis of HCC in the context of NAFLD-NASH, with a particular focus on the innate and the adaptive immune system, fibrogenesis and angiogenesis. We review the key roles of macrophages, hepatic stellate cells (HSCs), T cells, natural killer (NK) cells, NKT cells and liver sinusoidal endothelial cells (LSECs) and the role of the extracellular matrix in hepatocarcinogenesis within the steatotic milieu.
引用
收藏
页数:22
相关论文
共 50 条
  • [21] Pathogenesis of hepatocellular carcinoma development in non-alcoholic fatty liver disease
    Shetty K.
    Chen J.
    Shin J.-H.
    Jogunoori W.
    Mishra L.
    Current Hepatology Reports, 2015, 14 (2) : 119 - 127
  • [22] Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?
    Seo, Wonhyo
    Jeong, Won-Il
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (04) : 1348 - 1356
  • [23] Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis:Paving the way to hepatocellular carcinoma
    Matthias Ocker
    World Journal of Gastroenterology, 2020, (03) : 279 - 290
  • [24] Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
    Ocker, Matthias
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (03) : 279 - 290
  • [25] Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
    Grgurevic, Ivica
    Bozin, Tonci
    Mikus, Mislav
    Kukla, Michal
    O'Beirne, James
    CANCERS, 2021, 13 (22)
  • [26] Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease
    Maki Tobari
    Etsuko Hashimoto
    Makiko Taniai
    Takayoshi Nishino
    Katsutoshi Tokushige
    Clinical Journal of Gastroenterology, 2020, 13 : 1289 - 1296
  • [27] Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma
    Talamantes, Stephanie
    Lisjak, Michela
    Gilglioni, Eduardo H.
    Llamoza-Torres, Camilo J.
    Ramos-Molina, Bruno
    Gurzov, Esteban N.
    JHEP REPORTS, 2023, 5 (09)
  • [28] Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
    Afonso, Marta B.
    Rodrigues, Pedro M.
    Simao, Andre L.
    Castro, Rui E.
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (03)
  • [29] Autophagy and Non-Alcoholic Fatty Liver Disease
    Lavallard, Vanessa J.
    Gual, Philippe
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity
    Van Herck, Mikhail A.
    Weyler, Jonas
    Kwanten, Wilhelmus J.
    Dirinck, Eveline L.
    De Winter, Benedicte Y.
    Francque, Sven M.
    Vonghia, Luisa
    FRONTIERS IN IMMUNOLOGY, 2019, 10